HPC Offered for PRESERVE Expansion

RecruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

June 27, 2024

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2029

Conditions
Bone Marrow Transplant (BMT)
Interventions
OTHER

Bone Marrow Transplant with Ossium's HPC, Marrow (bone marrow recovered from deceased organ and tissue donors)

The HOPE Program does not include any investigational drugs. The medicines and procedures in this program are standard of care for a transplant. Bone marrow cells from a deceased organ and tissue donor for use in your transplant is the only product offered to you by Ossium Health.

Trial Locations (4)

35294

RECRUITING

University of Alabama, Birmingham, Birmingham

37203

RECRUITING

Tristar Centennial Medical Center, Nashville

43210

RECRUITING

The Ohio State University Medical Center, Columbus

48202

RECRUITING

Henry Ford Health, Detroit

Sponsors
All Listed Sponsors
lead

Ossium Health, Inc.

INDUSTRY

NCT07145411 - HPC Offered for PRESERVE Expansion | Biotech Hunter | Biotech Hunter